17 May 2023

German Tax Aspects for Inbound Investments

There is a multitude of factors to be considered when investments in Germany are envisaged. We have summarized some German key tax issues such as the applicable (corporate) income tax rates, the basics of the German thin cap rules or the treatment of tax losses.

Print


Press contact
presse@gsk.de
+49 30 203907-7763

Back

GSK Updates
  • 02 June 2023

    GSK Update: Comprehensive VAT exemption for management of alternative investment funds (AIFs) planned in Germany

    Read more
  • 17 May 2023

    GSK Update: German Tax Aspects for Inbound Investments

    Read more
  • 05 May 2023

    GSK Update: Real Estate Investments in Germany from a Tax Perspective

    Read more
Contact person

Dr. Petra Eckl

Partner*

+49 69 710003-0

petra.eckl@gsk.de

Dr. Dirk Koch

Partner*

+49 89 288174-676

dirk.koch@gsk.de

Dominik Berka

Local Partner*

+49 69 710003-194

dominik.berka@gsk.de

Felix Schill, LL.M.

Counsel

+49 69 710003-199

felix.schill@gsk.de

Esther Seibt-Pfitzner

Senior Associate

+49 89 288174 - 676

esther.seibt-pfitzner@gsk.de

Stephan Wachsmuth, LL.M.

Associate

+49 89 288174-676

stephan.wachsmuth@gsk.de

Sebastian Gerhards

Senior Associate

+49 89 288174-95

sebastian.gerhards@gsk.de

Marc Nostitz

Senior Associate

+49 69 710003-193

marc.nostitz@gsk.de

For reasons of better readability, we use the gender-neutral generic masculine. However, the information expressly refers to all genders.

CO2 Neutral